SCHEMBL770795

SCHEMBL770795

CN(C(=O)CCNC(=O)N1CCCC2CCCCC21)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 1/20 0.39
NPBWR1 P48145 1/20 0.39
KMT2A Q03164 1/20 0.39
CNR2 P34972 1/20 0.38
PDE3B Q13370 5/20 0.37
PDE3A Q14432 5/20 0.37
PDE2A O00408 4/20 0.37
P2RY12 Q9H244 4/20 0.37
ATM Q13315 1/20 0.36
PABPC1 P11940 1/20 0.36
AHCY P23526 1/20 0.36
HPGD P15428 1/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802885 0.93 NPC1 (0.41) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL771173 0.85 NPC1 (0.43) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL770849 0.83 NPC1 (0.41) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL771376 0.81 NPC1 (0.40) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL794796 0.81 ALDH1A1 (0.39) POLBTDP1ALDH1A1PKMMEN1
SCHEMBL770208 0.80 NPC1 (0.54) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL769965 0.80 NPC1 (0.50) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL770358 0.79 NPC1 (0.47) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL771423 0.79 ALDH1A1 (0.40) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL771069 0.78 NPC1 (0.51) NPC1RAB9ASMN1; SMN2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 NPC1 97/4885RAB9A 2187/4885SMN1; SMN2 3653/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 NPC1 104/4885RAB9A 2217/4885SMN1; SMN2 3637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.